Fig. 2From: Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinomaAssociation of 20q13.33 gain and clinicopathological features in CRC patients. Clinicopathological features are gender (a), age (b), AJCC stage including early (I / II) and late (III / IV) stages (c), location (d) as well as differentiation level of tumor (e), and status of microsatellite instability (f). ** P < 0.01, *** P < 0.001Back to article page